| scholarly article | Q13442814 |
| P356 | DOI | 10.1093/OXFORDJOURNALS.JBCHEM.A122699 |
| P698 | PubMed publication ID | 2668261 |
| P2093 | author name string | I Kudo | |
| K Inoue | |||
| M Murakami | |||
| D K Kim | |||
| M Tomita | |||
| M Hayakawa | |||
| E Kondo | |||
| K Horigome | |||
| H Mizushima | |||
| P433 | issue | 4 | |
| P1104 | number of pages | 6 | |
| P304 | page(s) | 520-525 | |
| P577 | publication date | 1989-04-01 | |
| P1433 | published in | Journal of Biochemistry | Q6294839 |
| P1476 | title | Purification of rabbit platelet secretory phospholipase A2 and its characteristics | |
| P478 | volume | 105 |
| Q42822458 | A novel phospholipase A2 from human placenta |
| Q40993744 | Action of human group IIa secreted phospholipase A2 on cell membranes. Vesicle but not heparinoid binding determines rate of fatty acid release by exogenously added enzyme |
| Q36366671 | Antigen-induced generation of lyso-phospholipids in human airways. |
| Q44416213 | Characterization of extracellular phospholipase A2 (PLA2) activity in fluid and peritoneal cells from casein-treated rats |
| Q72401171 | Detection of two phospholipase A2(PLA2) activities in leaves of higher plant Vicia faba and comparison with mammalian PLA2's |
| Q46960477 | Exacerbation of rat adjuvant arthritis by intradermal injection of purified mammalian 14-kDa group II phospholipase A2. |
| Q37354905 | Expression of human group II PLA2 in transgenic mice results in epidermal hyperplasia in the absence of inflammatory infiltrate |
| Q67929050 | Extracellular phospholipase A2 detected at inflamed sites in rats does not originate from platelets |
| Q67846486 | Interleukin-1α stimulates the release of prostaglandin E2 and phospholipase A2 from fetal rat calvarial cells in vitro: Relationship to bone nodule formation |
| Q42752618 | Mechanism of inhibition of protein kinase C by 14-3-3 isoforms. 14-3-3 isoforms do not have phospholipase A2 activity |
| Q41006874 | Mechanisms that account for the selective release of arachidonic acid from intact cells by secretory phospholipase A2. |
| Q37178113 | Phospholipid-mediated signaling in receptor activation of human platelets |
| Q67988854 | Purification and characterization of human platelet phospholipase A2 which preferentially hydrolyzes an arachidonoyl residue |
| Q71793354 | Purification and characterization of nuclear alkaline phospholipase A2 in rat ascites hepatoma cells |
| Q34395731 | Raised serum activity of phospholipase A2 immunochemically related to group II enzyme in inflammatory bowel disease: its correlation with disease activity of Crohn's disease and ulcerative colitis |
| Q35763079 | Regulation of arachidonic acid, eicosanoid, and phospholipase A2 levels in murine mast cells by recombinant stem cell factor |
| Q42160022 | Release of secretory phospholipase A2 from rat neuronal cells and its possible function in the regulation of catecholamine secretion |
| Q41971511 | Structure of an engineered porcine phospholipase A2 with enhanced activity at 2.1 A resolution. Comparison with the wild-type porcine and Crotalus atrox phospholipase A2. |
| Q68169115 | Studies on phospholipase A2 in human seminal plasma |
| Q74012752 | The perturbed membrane of cells undergoing apoptosis is susceptible to type II secretory phospholipase A2 to liberate arachidonic acid |
| Q39759518 | The potent anti-Staphylococcus aureus activity of a sterile rabbit inflammatory fluid is due to a 14-kD phospholipase A2. |
| Q27676102 | X-ray structure of phospholipase A2 complexed with a substrate-derived inhibitor |
Search more.